Skip to content

Viscosupplementation and platelet-rich plasma in knees chondral injuries.

Comparison between viscosupplementation and PRP in Knees chondral lesions in young patients.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9zgdbb
Enrollment
Unknown
Registered
2017-01-23
Start date
2016-12-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tear of articular cartilage of knee, current

Interventions

Knee intraarticular application of Platelet-rich plasma or viscossuplementation (Hialuronate application). In a group of 50 patients it will be applied 2 ml of hialuronate (Fermathrom) in the affected
Drug
Procedure/surgery

Sponsors

Uniort.E Ortopedia Especializada
Lead Sponsor
Uniort.E Ortopedia Especializada
Collaborator

Eligibility

Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Chondral injury in just one knee; age between 20 and 40 years old; both genders; BMI under 30.

Exclusion criteria

Exclusion criteria: Presence of osteoarthritis; allergy to blood components.

Design outcomes

Primary

MeasureTime frame
Assessment of the functional response at the end of the treatments, looking for the most effective treatment. The expected outcome is both treatment have improvement effect in the patients articular function. The assessment will be done by WOMAC Score application. These Score will be applied at the end of last application (with 3 weeks), 3 months, 6 months and 1 year. Groups will be compared in relation to the score results. The WOMAC form evaluate with points the patients function, giving a final score. By this way we could have a better score after treatments and could compare both treatments percentage.;Assesmente of pain at the end of 1 year of treatment, evaluating with treatment was more effective. The expected outcome is that both treatments have pain relief effect in patients. The evaluation will be done by Visual Analogic Pain (VAP) scale. These scale will be applied at the end of last application (with 3 weeks), 3 months, 6 months and 1 year. Groups will be compared in relation to the scale results. The VAP gives a number that corresponds to the degree of pain. We expect that this number will decrease with treatments, and thus it will be possible to compare groups in relation to the percentage of decrease.

Secondary

MeasureTime frame
Complication index or complains related to each kind of treatment. According to the report recorded in the medical records. Thereby we could compare percentages to find the most confortable treatment. Assessment will be done by comparing recording incidences.

Countries

Brazil

Contacts

Public ContactMarcus Danieli

Uniort.E Ortopedia Especializada

mvdanieli@hotmail.com+55(43)33770900

Outcome results

None listed

Source: REBEC (via WHO ICTRP)